Bank Ganesha Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Bank Ganesha Tbk trades at Rp110 (market cap 2.59T, 543.6K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 1.44M 24h volume). The key difference: Bank Ganesha Tbk is far larger — about 4.4× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (1.44M versus 543.6K). Which is the better fit depends on your goals.
| BGTG | LABS | |
|---|---|---|
Market Cap | 2.59T | 584.6B |
Volume | 543.6K | 1.44M |
Lot | 5.44K | 14.4K |
Turnover | 59.52M | 209.72M |
Average Price | 109.49 | 145.64 |
Value | 59.52M | 209.72M |
Indicative Equilibrium Price | 110 | 146 |
Indicative Equilibrium Volume | 87 | 753 |
Trailing returns across standard periods
Latest headlines on both assets
P.T. Bank Ganesha Tbk (”the Bank”) was established based on Deed No. 47 dated May 15, 1990 of notary Esther Daniar Iskandar S.H. The Bank started commercial operations on April 30, 1992 when it obtained its business license based on the Decision Letter No. 393/KMK-013/1992 dated April 14, 1992 from the Minister of Finance of the Republic of Indonesia. In accordance with Bank Indonesia’sDecision Letter No. 26/66/KEP/DIR dated September 12, 1995, the Bank is authorized to be a foreign exchange bank.
Read more on BGTG →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →